Registry of Patient With M. Dupuytren and Validation of the Brief MHQ

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by Schulthess Klinik
Information provided by (Responsible Party):
Daniel Herren, Schulthess Klinik Identifier:
First received: June 10, 2013
Last updated: February 26, 2014
Last verified: February 2014

The purpose of this study is the validation of the Brief Michigan Hand Questionnaire by patient with Morbus Dupuytren and to build up a register.

Condition Intervention
Dupuytren Contracture
Collagen Shrinkage
Procedure: Xiaflex surgery

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 3 Years
Official Title: Buildup of a Registry of Patient With M. Dupuytren and Validation of the Brief Michigan Hand Questionnaire

Resource links provided by NLM:

Further study details as provided by Schulthess Klinik:

Primary Outcome Measures:
  • Brief Michigan Hand Questionnaire [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    Patient reported outcome measurement by hand disorders

Secondary Outcome Measures:
  • Joint mobility [ Time Frame: 3 years ] [ Designated as safety issue: No ]
    Measuring the joint mobility of the fingers with the goniometer

Other Outcome Measures:
  • Pain [ Time Frame: 3 years ] [ Designated as safety issue: No ]
    Measuring pain with the Numeric rating scale

  • Grip Strength [ Time Frame: 3 years ] [ Designated as safety issue: No ]
    Measuring grip strength with the dynamometer

  • Quick DASH [ Time Frame: 3 year ] [ Designated as safety issue: No ]
    Patient reported outcome measurement by arm, shoulder and hand disorders

  • Euroqol 5l5d [ Time Frame: 3 years ] [ Designated as safety issue: No ]
    analysis of the costs and utilities

  • Michigan Hand Questionnaire [ Time Frame: 3 years ] [ Designated as safety issue: No ]
    Patient reported outcome measurement by hand disorders

Estimated Enrollment: 60
Study Start Date: August 2013
Estimated Study Completion Date: June 2017
Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Patient with M. Dupuytren
Xiaflex Surgery
Procedure: Xiaflex surgery
Xiaflex surgery

Detailed Description:

examination of the characteristics of Patient with Morbus Dupuytren and the psychometric properties of the Brief Michigan Hand Questionnaire by this patients


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

patients with M.Dupuytren with Xiapex injection or surgery


Inclusion Criteria:

  • M.Dupuytren, over 18y, able to speak and understand german

Exclusion Criteria:

  • recurrence, pregnancy, incapable of contracting
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01876498

Schulthess Klinik Recruiting
Zurich, Switzerland, 8008
Contact: Daniel Herren,    +41(0)443857481   
Principal Investigator: Daniel Herren, Dr. med.         
Sponsors and Collaborators
Schulthess Klinik
Study Chair: Daniel Herren, Dr. med. Schulthess Klinik
  More Information

No publications provided

Responsible Party: Daniel Herren, Dr. med. Daniel Herren, Schulthess Klinik Identifier: NCT01876498     History of Changes
Other Study ID Numbers: Brief MHQ1, Dupuytren 1
Study First Received: June 10, 2013
Last Updated: February 26, 2014
Health Authority: Switzerland: Ethikkommission

Additional relevant MeSH terms:
Dupuytren Contracture
Joint Diseases
Musculoskeletal Diseases
Muscular Diseases
Connective Tissue Diseases processed this record on September 30, 2014